One of our Trustees and funded researchers, Professor Sir Robert Lechler, has been elected as the new President of the Academy of Medical Sciences.
Professor Lechler will take up the position from 4 December 2015 when the current President, Professor Sir John Tooke, finishes his term.
The Academy of Medical Sciences is an independent body that represents the diversity of medical science. Their aim is to promote medical research and its translation into medical applications that benefit society. We are partners with them on a grant funding scheme that helps medical doctors to stay in research rather than pursuing an entirely clinical career.
Long-standing support for the BHF
Sir Robert has been one of our Trustees since 2010 and he is currently Vice-Principal (Health) at King's College London, where we have a Centre of Research Excellence. In the past he received one of our Programme Grants where he led research into improving heart transplantation by reducing rejection of the donor heart. He is now a co-applicant on a Programme Grant that continues his earlier work.
Professor Lechler has had a long-standing connection with us - he also served a term as Chair of one of our grant committees. These consider applications for funding from UK cardiovascular researchers. He was knighted in 2012 for services to academic medicine.
Promoting innovation and collaboration
Upon being announced as President, Professor Sir Robert Lechler said: "I am delighted to lead such a prestigious and influential organisation. The Academy has achieved much in its short history and I look forward to working with the Fellowship and staff to continue to build its national prominence and influence.
"This is a challenging period for medical science, but there are many opportunities to be realised. In my role as Academy President I will strive to promote innovation and collaboration and to ensure that the Academy continues to represent excellence in medical science in its broadest sense."
Find out more about how our research funding has driven improvements in heart transplants.
Help us fund more breakthroughs that save lives.